Thrombocytopenia
|
phenotype |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
592
|
110
|
0.900 |
strong |
0.947 |
19 |
3
|
1995 |
2020 |
Thrombocytopenia, Platelet Dysfunction, Hemolysis, and Imbalanced Globin Synthesis
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
12
|
0.700 |
strong |
1.000 |
23 |
12
|
1977 |
2014 |
Anemia, Diamond-Blackfan
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
86
|
38
|
0.700 |
strong |
1.000 |
21 |
4
|
1996 |
2019 |
THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA
|
disease |
|
Disease or Syndrome
|
1
|
5
|
0.700 |
None |
1.000 |
11 |
5
|
2000 |
2018 |
ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES
|
disease |
|
Disease or Syndrome
|
1
|
3
|
0.700 |
strong |
1.000 |
6 |
3
|
2000 |
2018 |
Porphyria, Erythropoietic
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
20
|
26
|
0.550 |
None |
1.000 |
5 |
1
|
2001 |
2019 |
Acute Megakaryocytic Leukemias
|
disease |
Neoplasms
|
Neoplastic Process
|
159
|
15
|
0.500 |
None |
0.955 |
66 |
1
|
2002 |
2018 |
Anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
847
|
94
|
0.500 |
strong |
1.000 |
12 |
3
|
2000 |
2019 |
Hematopoetic Myelodysplasia
|
phenotype |
Hemic and Lymphatic Diseases
|
Pathologic Function
|
38
|
|
0.500 |
None |
1.000 |
2 |
|
1998 |
2017 |
Dyserythropoietic Anemia with Thrombocytopenia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
3
|
0.430 |
None |
1.000 |
9 |
3
|
1996 |
2014 |
Down Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
766
|
80
|
0.400 |
None |
0.981 |
104 |
|
2002 |
2020 |
MYELOPROLIFERATIVE SYNDROME, TRANSIENT
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
105
|
9
|
0.400 |
None |
0.970 |
67 |
|
2003 |
2020 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.400 |
None |
1.000 |
17 |
1
|
1999 |
2020 |
Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
389
|
97
|
0.400 |
strong |
1.000 |
1 |
|
2012 |
2012 |
Acute Basophilic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
5
|
|
0.320 |
None |
1.000 |
2 |
|
2011 |
2019 |
Transient Myeloproliferative Disorder of Down Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
|
0.310 |
None |
1.000 |
2 |
|
2003 |
2013 |
Aase Smith syndrome 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
16
|
5
|
0.300 |
None |
1.000 |
2 |
|
2012 |
2014 |
Deficiency of Uroporphyrinogen III Synthase
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
3
|
2
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Abnormality of radial ray
|
phenotype |
|
Finding
|
34
|
|
0.300 |
moderate |
|
0 |
|
|
|
Down Syndrome, Partial Trisomy 21
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
|
0 |
|
|
|
Trisomy 21, Meiotic Nondisjunction
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
|
0 |
|
|
|
Trisomy 21, Mitotic Nondisjunction
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
|
0 |
|
|
|
Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
282
|
29
|
0.290 |
None |
1.000 |
11 |
|
2001 |
2020 |
Myelofibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
163
|
7
|
0.270 |
None |
1.000 |
9 |
|
2001 |
2020 |
Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
365
|
43
|
0.200 |
None |
1.000 |
11 |
|
2003 |
2020 |